Brief: Angion Reports Q3 Loss Per Share Of 53 Cents

Elicio Therapeutics

12/11/2021 12:29

Nov 12 (Reuters) - Angion Biomedica Corp  ANGN.O :
    * ANGION PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER
2021
FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.53
    * EXPECTS CURRENT CASH RESOURCES TO BE SUFFICIENT TO FUND
PLANNED
OPERATIONS THROUGH END OF 2022

Source text for Eikon:  ID:nGNX6pTwnr 
Further company coverage:  ANGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))